180 related articles for article (PubMed ID: 37107122)
21. Eugenol works synergistically with colistin against colistin-resistant
Kong J; Wang Y; Yao Z; Lin Y; Zhang Y; Han Y; Zhou T; Ye J; Cao J
Microbiol Spectr; 2023 Sep; 11(5):e0366622. PubMed ID: 37707450
[TBL] [Abstract][Full Text] [Related]
22. Synergy by Perturbing the Gram-Negative Outer Membrane: Opening the Door for Gram-Positive Specific Antibiotics.
Wesseling CMJ; Martin NI
ACS Infect Dis; 2022 Sep; 8(9):1731-1757. PubMed ID: 35946799
[TBL] [Abstract][Full Text] [Related]
23. Antibiotic Potentiation in Multidrug-Resistant Gram-Negative Pathogenic Bacteria by a Synthetic Peptidomimetic.
Mood EH; Goltermann L; Brolin C; Cavaco LM; Nejad AJ; Yavari N; Frederiksen N; Franzyk H; Nielsen PE
ACS Infect Dis; 2021 Aug; 7(8):2152-2163. PubMed ID: 34227804
[TBL] [Abstract][Full Text] [Related]
24. Polymyxin B combinations with FDA-approved non-antibiotic phenothiazine drugs targeting multi-drug resistance of Gram-negative pathogens.
Hussein M; Hu X; Paulin OKA; Crawford S; Tony Zhou Q; Baker M; Schneider-Futschik EK; Zhu Y; Li J; Velkov T
Comput Struct Biotechnol J; 2020; 18():2247-2258. PubMed ID: 32952938
[TBL] [Abstract][Full Text] [Related]
25. Breaking antimicrobial resistance by disrupting extracytoplasmic protein folding.
Furniss RCD; Kaderabkova N; Barker D; Bernal P; Maslova E; Antwi AAA; McNeil HE; Pugh HL; Dortet L; Blair JMA; Larrouy-Maumus G; McCarthy RR; Gonzalez D; Mavridou DAI
Elife; 2022 Jan; 11():. PubMed ID: 35025730
[TBL] [Abstract][Full Text] [Related]
26. The effect of EDTA in combination with some antibiotics against clinical isolates of gram negative bacteria in Mansoura, Egypt.
Aboelenin AM; Hassan R; Abdelmegeed ES
Microb Pathog; 2021 May; 154():104840. PubMed ID: 33691177
[TBL] [Abstract][Full Text] [Related]
27.
Chen H; Li H; Liu Z; Li J
Microb Drug Resist; 2020 Sep; 26(9):1108-1119. PubMed ID: 32349617
[TBL] [Abstract][Full Text] [Related]
28. Synergy of outer membrane disruptor SLAP-S25 with hydrophobic antibiotics against Gram-negative pathogens.
Yang Z; Song M; Li X; Zhang Q; Shen J; Zhu K
J Antimicrob Chemother; 2022 Dec; 78(1):263-271. PubMed ID: 36385317
[TBL] [Abstract][Full Text] [Related]
29. SPR741, Double- or Triple-Combined With Erythromycin and Clarithromycin, Combats Drug-Resistant
She P; Liu Y; Xu L; Li Y; Li Z; Liu S; Hussain Z; Wu Y
Front Cell Infect Microbiol; 2022; 12():858606. PubMed ID: 35372124
[No Abstract] [Full Text] [Related]
30. Structure-Activity Studies with Bis-Amidines That Potentiate Gram-Positive Specific Antibiotics against Gram-Negative Pathogens.
Wesseling CMJ; Slingerland CJ; Veraar S; Lok S; Martin NI
ACS Infect Dis; 2021 Dec; 7(12):3314-3335. PubMed ID: 34766746
[TBL] [Abstract][Full Text] [Related]
31. Restoring the activity of the antibiotic aztreonam using the polyphenol epigallocatechin gallate (EGCG) against multidrug-resistant clinical isolates of
Betts JW; Hornsey M; Higgins PG; Lucassen K; Wille J; Salguero FJ; Seifert H; La Ragione RM
J Med Microbiol; 2019 Oct; 68(10):1552-1559. PubMed ID: 31419210
[No Abstract] [Full Text] [Related]
32. The cathelicidin-derived close-to-nature peptide D-11 sensitises Klebsiella pneumoniae to a range of antibiotics in vitro, ex vivo and in vivo.
Cebrián R; Xu C; Xia Y; Wu W; Kuipers OP
Int J Antimicrob Agents; 2021 Nov; 58(5):106434. PubMed ID: 34525402
[TBL] [Abstract][Full Text] [Related]
33. Synergistic antibacterial effect of inhaled aztreonam and tobramycin fixed dose combination to combat multidrug-resistant Gram-negative bacteria.
Wang J; Kutter JP; Mu H; Moodley A; Yang M
Int J Pharm; 2020 Nov; 590():119877. PubMed ID: 32927003
[TBL] [Abstract][Full Text] [Related]
34. Synergistic activity between colistin and the ionic liquids 1-methyl-3-dodecylimidazolium bromide, 1-dodecyl-1-methylpyrrolidinium bromide, or 1-dodecyl-1-methylpiperidinium bromide against Gram-negative bacteria.
Florio W; Rizzato C; Becherini S; Guazzelli L; D'Andrea F; Lupetti A
J Glob Antimicrob Resist; 2020 Jun; 21():99-104. PubMed ID: 32298808
[TBL] [Abstract][Full Text] [Related]
35. Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens.
Pollini S; Brunetti J; Sennati S; Rossolini GM; Bracci L; Pini A; Falciani C
J Pept Sci; 2017 Apr; 23(4):329-333. PubMed ID: 28176481
[TBL] [Abstract][Full Text] [Related]
36. Cell-wall-inhibiting antibiotic combinations with activity against multidrug-resistant Klebsiella pneumoniae and Escherichia coli.
Hickman RA; Hughes D; Cars T; Malmberg C; Cars O
Clin Microbiol Infect; 2014 Apr; 20(4):O267-73. PubMed ID: 24118201
[TBL] [Abstract][Full Text] [Related]
37. Designing peptide amphiphiles as novel antibacterials and antibiotic adjuvants against gram-negative bacteria.
Xing H; Loya-Perez V; Franzen J; Denton PW; Conda-Sheridan M; Rodrigues de Almeida N
Bioorg Med Chem; 2023 Oct; 94():117481. PubMed ID: 37776750
[TBL] [Abstract][Full Text] [Related]
38. Rapid Freezing Enables Aminoglycosides To Eradicate Bacterial Persisters via Enhancing Mechanosensitive Channel MscL-Mediated Antibiotic Uptake.
Zhao Y; Lv B; Sun F; Liu J; Wang Y; Gao Y; Qi F; Chang Z; Fu X
mBio; 2020 Feb; 11(1):. PubMed ID: 32047133
[TBL] [Abstract][Full Text] [Related]
39. Synergistic effect of artocarpin on antibacterial activity of some antibiotics against methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli.
Septama AW; Panichayupakaranant P
Pharm Biol; 2016; 54(4):686-91. PubMed ID: 26427318
[TBL] [Abstract][Full Text] [Related]
40. Enhanced efficacy of putative efflux pump inhibitor/antibiotic combination treatments versus MDR strains of Pseudomonas aeruginosa in a Galleria mellonella in vivo infection model.
Adamson DH; Krikstopaityte V; Coote PJ
J Antimicrob Chemother; 2015 Aug; 70(8):2271-8. PubMed ID: 25921513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
